Top Suppliers:I want be here


2241019-57-6

2241019-57-6 structure
2241019-57-6 structure
  • Name: NAMPT inhibitor-linker 1
  • Chemical Name: NAMPT inhibitor-linker 1
  • CAS Number: 2241019-57-6
  • Molecular Formula: C36H37FN6O6
  • Molecular Weight: 668.71
  • Catalog: Signaling Pathways Antibody-drug Conjugate Drug-Linker Conjugates for ADC
  • Create Date: 2019-03-03 10:07:07
  • Modify Date: 2024-01-11 10:55:01
  • NAMPT inhibitor-linker 1 is a drug-linker conjugates for ADC, composed of an NAMPT inhibitor as a payload, and a linker. ADC-3 consists of an NAMPT inhibitor-linker 1 and an anti-c-Kit monoclonal antibody, exihibits potent activity against c-Kit expressing cell lines such as GIST-T1 and NCI-H526 cells, with IC50s of <3 pM and 9 pM, respectively.

Name NAMPT inhibitor-linker 1
Description NAMPT inhibitor-linker 1 is a drug-linker conjugates for ADC, composed of an NAMPT inhibitor as a payload, and a linker. ADC-3 consists of an NAMPT inhibitor-linker 1 and an anti-c-Kit monoclonal antibody, exihibits potent activity against c-Kit expressing cell lines such as GIST-T1 and NCI-H526 cells, with IC50s of <3 pM and 9 pM, respectively.
Related Catalog
In Vitro ADC-3 exihibits potent activity against c-Kit expressing cell lines such as GIST-T1 and NCI-H526, with IC50s of <3 pM and 9 pM, respectively[1].
In Vivo ADC-3 (20 mg/kg, i.v. for 28 days) is tolerated, and causes tumor stasis in mice bearing GIST-T1 cells[1]. Animal Model: Female scid-beige (SCID bg) mice[1] Dosage: 20 mg/kg Administration: A single intravenous injection (i.v.) for 28 days Result: Significantly inhibited the growth of tumor in mice.
References

[1]. Karpov AS, et al. Nicotinamide Phosphoribosyltransferase Inhibitor as a Novel Payload for Antibody-Drug Conjugates. ACS Med Chem Lett. 2018 Jun 28;9(8):838-842.

Molecular Formula C36H37FN6O6
Molecular Weight 668.71
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.